Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Inventory (2016 - 2025)

Mimedx's Inventory history spans 15 years, with the latest figure at $25.3 million for Q4 2025.

  • For Q4 2025, Inventory rose 6.44% year-over-year to $25.3 million; the TTM value through Dec 2025 reached $25.3 million, up 6.44%, while the annual FY2025 figure was $25.3 million, 6.44% up from the prior year.
  • Inventory for Q4 2025 was $25.3 million at Mimedx, down from $26.5 million in the prior quarter.
  • Across five years, Inventory topped out at $26.5 million in Q3 2025 and bottomed at $10.1 million in Q2 2021.
  • The 5-year median for Inventory is $17.9 million (2023), against an average of $18.4 million.
  • The largest annual shift saw Inventory dropped 4.05% in 2021 before it skyrocketed 66.84% in 2024.
  • A 5-year view of Inventory shows it stood at $11.4 million in 2021, then increased by 15.75% to $13.2 million in 2022, then surged by 59.46% to $21.0 million in 2023, then rose by 13.25% to $23.8 million in 2024, then grew by 6.44% to $25.3 million in 2025.
  • Per Business Quant, the three most recent readings for MDXG's Inventory are $25.3 million (Q4 2025), $26.5 million (Q3 2025), and $24.9 million (Q2 2025).